創新藥物
創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1806.51 billion HKD，24h 漲跌幅 -0.33%，40 檔中，17 檔上漲 (42.50%)，21 檔下跌 (52.50%)。領漲個股為 四環醫藥 (00460)，24h 漲幅為 +6.81%。漲跌家數參差，板塊回落，但龍頭股表現相對優異。保持選擇性：圍繞臨床或政策催化事件操作；偏好現金充裕、處於後期臨床階段的研發管線，並在走弱時逢低加碼，因利率與給付/報銷訊號將影響估值。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 石藥集團01093 | HK$8.30$34.21 | -2.92%-$1.03 | HK$8.30 -2.92% | $34.17$35.24 | ||
 藥明生物02269 | HK$38.66$159.37 | -1.12%-$1.81 | HK$38.66 -1.12% | $158.63$163.49 | ||
 信達生物－Ｂ01801 | HK$89.35$368.34 | -0.66%-$2.47 | HK$89.35 -0.66% | $365.45$371.84 | ||
 藥明康德02359 | HK$157.0$647.2 | -0.25%-$1.6 | HK$157.0 -0.25% | $644.7$658.7 | ||
 百濟神州06160 | HK$199.7$823.2 | +0.25%+$2.0 | HK$199.7 +0.25% | $815.4$826.1 | ||
 金斯瑞生物科技01548 | HK$16.82$69.34 | +4.47%+$2.96 | HK$16.82 +4.47% | $66.24$69.34 | ||
 康方生物09926 | HK$98.60$406.47 | -0.90%-$3.71 | HK$98.60 -0.90% | $401.32$411.01 | ||
 晶泰控股02228 | HK$7.17$29.55 | -0.41%-$0.12 | HK$7.17 -0.41% | $28.61$29.97 | ||
 科倫博泰生物－Ｂ06990 | HK$513.5$2,116.8 | -0.09%-$2.0 | HK$513.5 -0.09% | $2,090.1$2,143.6 | ||
 三生製藥01530 | HK$17.13$70.61 | -0.86%-$0.61 | HK$17.13 -0.86% | $69.83$71.23 | ||
 榮昌生物09995 | HK$85.65$353.09 | +2.94%+$10.10 | HK$85.65 +2.94% | $342.99$355.56 | ||
 康諾亞－Ｂ02162 | HK$82.30$339.28 | -0.60%-$2.06 | HK$82.30 -0.60% | $335.36$343.40 | ||
 中國生物製藥01177 | HK$5.09$20.98 | -1.16%-$0.24 | HK$5.09 -1.16% | $20.90$21.27 | ||
 四環醫藥00460 | HK$0.94$3.87 | +6.81%+$0.24 | HK$0.94 +6.81% | $3.58$3.91 | ||
 藥明合聯02268 | HK$54.35$224.05 | -2.16%-$4.94 | HK$54.35 -2.16% | $222.20$232.09 | ||
 翰森製藥03692 | HK$32.30$133.15 | +0.18%+$0.24 | HK$32.30 +0.18% | $132.16$134.06 | ||
 恒瑞醫藥01276 | HK$57.05$235.18 | +0.70%+$1.64 | HK$57.05 +0.70% | $233.53$237.45 | ||
 先聲藥業02096 | HK$12.62$52.02 | -0.86%-$0.45 | HK$12.62 -0.86% | $51.53$52.76 | ||
 ZAI LAB09688 | HK$14.87$61.30 | -3.31%-$2.10 | HK$14.87 -3.31% | $60.64$63.60 | ||
 巨子生物02367 | HK$29.04$119.71 | +0.48%+$0.57 | HK$29.04 +0.48% | $119.13$121.69 |